These conclusions were drawn based on the detection of a positive correlation between the elevated level of circulating Apo-J and obesity, type 2 diabetes, inflammation, and, importantly, various CVDs including atherosclerosis, CAD, and myocardial infarction. The gene discussed is CLU; the disease is obesity disorder.